Bayesian Capital Management’s Cintas CTAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,301
Closed -$678K 214
2025
Q3
$678K Buy
+3,301
New +$705K 0.14% 222
2025
Q2
Sell
-27,100
Closed -$5.57M 609
2025
Q1
$5.57M Buy
+27,100
New +$5.4M 0.92% 13
2023
Q2
Sell
-2,380
Closed -$275K 832
2023
Q1
$275K Buy
+2,380
New +$262K 0.03% 537
2022
Q3
Sell
-4,816
Closed -$450K 749
2022
Q2
$450K Buy
4,816
+1,744
+57% +$170K 0.08% 362
2022
Q1
$327K Buy
+3,072
New +$299K 0.05% 495
2020
Q3
Sell
-6,636
Closed -$442K 550
2020
Q2
$442K Buy
+6,636
New +$384K 0.1% 264
2020
Q1
Sell
-8,000
Closed -$538K 807
2019
Q4
$538K Buy
+8,000
New +$526K 0.09% 298
2019
Q1
Sell
-28,800
Closed -$1.21M 586
2018
Q4
$1.21M Buy
+28,800
New +$1.29M 0.25% 116
2018
Q2
Sell
-12,400
Closed -$529K 621
2018
Q1
$529K Buy
+12,400
New +$514K 0.13% 260
2017
Q2
Sell
-29,200
Closed -$924K 459
2017
Q1
$924K Buy
+29,200
New +$864K 0.44% 52

Other funds holding CTAS

Bayesian Capital Management's CTAS Position: Q4 2025 in Review

Bayesian Capital Management sold out of Cintas (CTAS) in Q4 2025, closing a stake of 3,301 shares — an estimated $678K sold.

Bayesian Capital Management first reported a position in CTAS in Q1 2017 and held it in 10 quarters. The position peaked at $5.57M in Q1 2025. 1,471 funds tracked by Wall St. Rank hold CTAS as of Q4 2025.

  • Bayesian Capital Management reported no remaining Cintas position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 3,301 Cintas shares in Q4 2025, an estimated $678K.
  • Bayesian Capital Management first reported a position in Cintas in Q1 2017 and held it in 10 quarters.
  • Bayesian Capital Management's Cintas position peaked at $5.57M in Q1 2025.
  • 1,471 funds tracked by Wall St. Rank held Cintas as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.